Helping health professionals communicate in the era of COVID-19
27 April 2020 The University of Melbourne‘s “Communicating COVID-19″ course is designed for a wide range of healthcare providers both in hospital and community settings and will help provide expert-informed answers to questions Australian health care practitioners face surrounding…
Free access to Clarivate’s BioWorld coronavirus articles
30 April 2020 Clarivate have provided free access to COVID-19 content in their BioWorld suite of news services. Viewers can access general news as well as three critical tables summarising: Vaccines and therapeutics in development Diagnostics on the…
Toyota supports Melbourne hospitals with locally designed face shields
26 April 2020 Toyota has utilised its advanced design, technology and production expertise to help assist the medical community in protecting them from the COVID-19 virus by developing and manufacturing desperately needed face shields. The face shields were…
Personalised nutrition smart patch to be developed in Australia
27 April 2020 A wearable smart patch will deliver precision data to help people personalise their diets and reduce their risk of developing lifestyle-related chronic diseases like Type 2 diabetes. The world-first personalised nutrition wearable being developed by…
Offspring may inherit legacy of their father’s Toxoplasma infection
29 April 2020 Melbourne researchers at the Walter and Eliza Hall Institute have revealed for the first time that males infected with the Toxoplasma parasite can impact their offspring’s brain health and behaviour. Studying mice infected with the common parasite Toxoplasma,…
Cracking the COVID-19 immunity code
29 April 2020 Monash University’s Dr James McMahon, an infectious disease expert and hospital clinician at The Alfred and Monash Health, is leading the development of a biobank aimed at cracking the immunity code of COVID-19. The biobank enables…
UQ COVID-19 vaccine shown to induce potent protective response in pre-clinical trials
29 April 2020 The University of Queensland’s COVID-19 vaccine has passed another important milestone, showing the ability to raise high levels of antibodies that can neutralise the virus in early pre-clinical testing. UQ was tasked by the Coalition for Epidemic…
83% Survival in COVID-19 ARDS Patients with Remestemcel-L
24 April 2020 Mesoblast Limited (ASX:MSB; Nasdaq: MESO) today announced 83% survival in ventilator-dependent COVID-19 patients (10/12) with moderate/severe acute respiratory distress syndrome (ARDS) treated during the period March-April 2020 with two intravenous infusions of Mesoblast’s allogeneic mesenchymal…
Immutep Reports Positive Phase II TACTI-002 Data
28 April 2020 Immutep Limited (ASX: IMM; NASDAQ: IMMP), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, announces further positive interim data from its ongoing Phase II TACTI-002 study. The data relates to the…
New type of immune cell discovered in breast ducts
28 April 2020 Melbourne breast cancer researchers have discovered a new type of immune cell that helps to keep breast tissue healthy by regulating a vital process within mammary ducts – the sites where milk is produced and…
Major Coronavirus Testing Blitz Targets 100,000
27 April 2020 Up to 100,000 Victorians will be tested for coronavirus over the next two weeks as part of a major testing blitz across the State, to better understand how the virus is spreading in the community…
Researchers create world’s first ultrasound biosensor
23 April 2020 Australian researchers have made a world-first breakthrough that has the potential to monitor the changes in pH levels and other responses to therapy in stroke and cancer patients. Researchers from Monash University and the Baker…
